Key Takeaways
- U.K. startups are moving to Gulf nations due to slow-moving regulations and barriers within the NHS, hindering AI integration into healthcare.
- Outdated infrastructure, complex regulations, and inconsistent governance create roadblocks.
- The UAE and Qatar are fast-tracking AI healthcare projects with better funding, faster deployment, and more supportive regulatory environments.
Artificial intelligence is set to transform healthcare. But while the U.K. has the talent and technology to lead this revolution, its slow-moving bureaucracy and fragmented regulations drive healthtech startups away.
Instead of wrestling red tape, AI firms are moving to lucrative Gulf markets to power their healthcare systems with AI.
AI Barriers in the U.K. Healthcare System
The U.K. has positioned itself as a healthtech superpower, attracting $1.8 billion of funding in the first quarter of 2025 alone, and dwarfing even fintech and enterprise software.
With world-class research institutions and hospitals, it should be the ideal place to build AI-driven healthcare tools.
But instead of scaling in the U.K., more and more startups are looking elsewhere, including to the UAE, Qatar, and other Gulf nations. Why? Because the barriers to implementation in the U.K. are too high.
The National Health Service (NHS) is not only the largest healthcare provider in the U.K. but also the greatest barrier to AI adoption.
Outdated infrastructure, overly complex data privacy regulations, and inconsistent governance create substantial hurdles, making it exceptionally difficult for startups to deploy even proven, compliant AI solutions.
Take the Foresight Project, the NHS’s flagship AI initiative for example. The scheme set out to detect future conditions like Parkinson’s disease based on historical health data.
The project collapsed after medical bodies blocked its progress, underscoring the difficulty that firms face trying to kick off AI projects.
If a government-backed project with the weight of the state behind it can’t get off the ground, what chance does a startup have?
We’ve experienced firsthand how cumbersome it can be to deploy AI tools into the NHS.
AI Regulation vs. Red TAPE
Despite our software meeting strict industry safeguards for ambient voice technology, we navigated miles of red tape and forked out thousands of pounds on consultancy fees.
While we were stuck at a red light, frustrated GPs were using “unregulated” software en masse.
The government’s approach has inadvertently stifled well-intentioned startups offering compliant solutions while unintentionally fostering the growth of unregulated AI tools.
Are regulations necessary for transcription software used outside of healthcare settings? That warrants further debate. However, one point remains clear: excessive bureaucracy drives users towards easier, unregulated alternatives.
Meanwhile, nearly half of NHS services still rely on manual, paper-based processes for tracking a patient’s journey through care.
AI has the potential to significantly automate and streamline these outdated practices, but only if the infrastructure and processes within the NHS can effectively integrate these technologies.
Unfortunately, I’m skeptical of the government’s ability to fix these inefficiencies soon.
A fundamental cultural shift is needed across the NHS, government agencies, and beyond. A shift that prioritises efficiency, embraces technological innovation, and actively removes barriers rather than creating them.
That’s where the Gulf nations stand out. The UAE is aggressively investing in AI, blockchain, and Web3 technologies to modernise its healthcare system.
The Case of Gulf Nations
Qatar, while borrowing from the EU and U.S. data standards, is pairing regulation with “fast lanes” for impactful projects and major infrastructure projects, including data centres and semiconductor partnerships to power AI growth.
In Doha, deployment is faster, funding is easier, and public institutions are more open to innovation. From smart clinics to AI-powered appointment scheduling, the region is embracing the next phase of medicine.
The U.K. still has enormous potential. Its healthtech ecosystem remains one of the most advanced in the world.
But unless the government matches its ambition with actions, reforming regulations, modernising NHS infrastructure, and embedding AI in public health priorities, it risks becoming a mere exporter of talent and innovation.
The U.K.’s chancellor holds the key to reversing the exodus. Rachel Reeves has pledged an extra £29bn NHS funding per year, with up to £10bn reserved for technology and digital transformation. But it isn’t clear exactly how AI will be a core part of that investment.
The NHS faces an uncertain future. Against a backdrop of surging demand for health services and dwindling funds, it is left with one critical choice: embrace AI and technological innovation or risk being left behind.
The window to lead in AI-driven healthcare is rapidly closing. If the U.K. doesn’t act soon, the future of healthtech will undoubtedly be built elsewhere.
Recommended Secure Partners
The views, thoughts, and opinions expressed in the article belong solely to the author, and not necessarily to CCN, its management, employees, or affiliates. This content is for informational purposes only and should not be considered professional advice.
About the Author
Dr Zaid Al-Fagih is the Co-Founder and CEO of Rhazes AI, an award-winning AI-powered virtual assistant. The tool empowers doctors by boosting clinical productivity, reducing medical errors and burnout, and restoring the human connection in medicine. Prior to founding Rhazes AI, Dr Al-Fagih practiced full-time as a medical doctor in the NHS, and was a voluntary first responder and first aid trainer on humanitarian missions during the Syrian conflict. He has published research in leading journals on applying emerging technologies to healthcare, most recently in the Emergency Medical Journal.
